MedPath

The Study of Glycemic Index of NEO-MUNE

Phase 4
Completed
Conditions
glycemic index of NEO&#45
MUNE (medical food for patients who need high protein and high calories)
Registration Number
TCTR20170906002
Lead Sponsor
Thai Otsuka Pharmaceutical Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
10
Inclusion Criteria

1.18 years of age as the minimum age
2.Body Mass Index in the range of 18.5 - 24.9 kg/m2
3.Do not have any underlying disease
4.Do not have a family history of diabetes
5.Do not have any allergy of any component in the formula such as protein in cow milk, Glutamine, Arginine, fish oil etc.
6.Consent to participate the study and sign in the consent form with the understanding of detail and be able to follow the process

Exclusion Criteria

1.Having underlying disease such as diabetes, hypertension, heart and vascular disease, hepatic disease, kidney disease and disease which affect the metabolism such as thyroid disease etc.
2.Having medication, dietary supplement and vitamin within 7 days prior to the study
3.Pregnant or breastfeeding subject
4.Unable to follow the study process

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ow glycemic index 0, 30, 60, 90, 120 minutes AUC of blood glucose
Secondary Outcome Measures
NameTimeMethod
/A N/A N/A
© Copyright 2025. All Rights Reserved by MedPath